DelveInsight’s “Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an ...

DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

Teva stock plunged Wednesday — sacrificing an earlier breakout — despite beating third-quarter expectations and raising its guidance.

Reports Q3 revenue $4.3B, consensus $4.12B. Richard Francis, Teva‘s (TEVA) President and CEO, said, “The third quarter of 2024 ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Reorganizing its generics business strategy to target 60% instead of 80% of drugs coming off patent and reallocating resources to complex generics will help Teva offset base business erosion and ...

On October 31, 2024, the European Commission (EC) fined Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals Europe BV (Teva) ...

As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...

How will the U.S. election results impact healthcare stocks? Seeking Alpha analysts ONeil Trader, BioCGT Investor and Avisol ...

Operator Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited earnings conference call. My name is Alex, ...

Teva Zaveroni hails the performances of rising star Heimanu Terorotua at the OFC Beach Soccer Nations Cup and backs Tahiti to shine at Seychelles 2025.

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, ...